Cargando…

The pro- and anti-cancer effects of oxycodone are associated with epithelial growth factor receptor level in cancer cells

Background: Oxycodone is an opioid medication used for the treatment of pain in cancer patients. However, little is known on the direct effects of oxycodone on cancer cells. Aim: To determine the effects and mechanisms of oxycodone in cancer cells. Materials and Methods: Proliferation, survival and...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Yuqin, Li, Dapeng, Duan, Ji’an, Xu, Hongshuang, Li, Li, Tan, Dengwu, Yan, Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Portland Press Ltd. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7007405/
https://www.ncbi.nlm.nih.gov/pubmed/31967294
http://dx.doi.org/10.1042/BSR20193524
_version_ 1783495311335882752
author Yu, Yuqin
Li, Dapeng
Duan, Ji’an
Xu, Hongshuang
Li, Li
Tan, Dengwu
Yan, Hong
author_facet Yu, Yuqin
Li, Dapeng
Duan, Ji’an
Xu, Hongshuang
Li, Li
Tan, Dengwu
Yan, Hong
author_sort Yu, Yuqin
collection PubMed
description Background: Oxycodone is an opioid medication used for the treatment of pain in cancer patients. However, little is known on the direct effects of oxycodone on cancer cells. Aim: To determine the effects and mechanisms of oxycodone in cancer cells. Materials and Methods: Proliferation, survival and migration assays were performed on multiple types of cancer cells. Epithelial growth factor receptor (EGFR)/ERK/Akt pathway and oxidative stress were investigated after oxycodone treatment. Results: Oxycodone can either stimulate growth and migration without affecting survival in MDA-468 cells or inhibit growth and survival without affecting migration in SKBR3 and Caco2 cells. In addition, oxycodone can either attenuate or stimulate efficacy of chemotherapeutic drugs in cancer, depending on the type of cancer cells and nature of action of oxycodone as single drug alone. Our mechanism studies suggest that the stimulatory and inhibitory effects of oxycodone are associated with EGFR expression levels in cancer cells. In cancer cells with high EGFR level, oxycodone activates EGFR signaling in cancer cells, leading to stimulatory effects in multiple biological activities, and this is dependent on opioid receptor. In cancer cells with low EGFR level, oxycodone induces mitochondria-mediated caspase activity and oxidative stress and damage, leading to cell death. Conclusions: Our work is the first to demonstrate systematic analysis of oxycodone’s effects and mechanism of action in cancer. The activation of EGFR signaling by oxycodone may provide a new guide in the clinical use of oxycodone, in particular for cancer patients with high EGFR levels.
format Online
Article
Text
id pubmed-7007405
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Portland Press Ltd.
record_format MEDLINE/PubMed
spelling pubmed-70074052020-02-20 The pro- and anti-cancer effects of oxycodone are associated with epithelial growth factor receptor level in cancer cells Yu, Yuqin Li, Dapeng Duan, Ji’an Xu, Hongshuang Li, Li Tan, Dengwu Yan, Hong Biosci Rep Bioenergetics Background: Oxycodone is an opioid medication used for the treatment of pain in cancer patients. However, little is known on the direct effects of oxycodone on cancer cells. Aim: To determine the effects and mechanisms of oxycodone in cancer cells. Materials and Methods: Proliferation, survival and migration assays were performed on multiple types of cancer cells. Epithelial growth factor receptor (EGFR)/ERK/Akt pathway and oxidative stress were investigated after oxycodone treatment. Results: Oxycodone can either stimulate growth and migration without affecting survival in MDA-468 cells or inhibit growth and survival without affecting migration in SKBR3 and Caco2 cells. In addition, oxycodone can either attenuate or stimulate efficacy of chemotherapeutic drugs in cancer, depending on the type of cancer cells and nature of action of oxycodone as single drug alone. Our mechanism studies suggest that the stimulatory and inhibitory effects of oxycodone are associated with EGFR expression levels in cancer cells. In cancer cells with high EGFR level, oxycodone activates EGFR signaling in cancer cells, leading to stimulatory effects in multiple biological activities, and this is dependent on opioid receptor. In cancer cells with low EGFR level, oxycodone induces mitochondria-mediated caspase activity and oxidative stress and damage, leading to cell death. Conclusions: Our work is the first to demonstrate systematic analysis of oxycodone’s effects and mechanism of action in cancer. The activation of EGFR signaling by oxycodone may provide a new guide in the clinical use of oxycodone, in particular for cancer patients with high EGFR levels. Portland Press Ltd. 2020-02-07 /pmc/articles/PMC7007405/ /pubmed/31967294 http://dx.doi.org/10.1042/BSR20193524 Text en © 2020 The Author(s). https://creativecommons.org/licenses/by/4.0/ This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution License 4.0 (CC BY).
spellingShingle Bioenergetics
Yu, Yuqin
Li, Dapeng
Duan, Ji’an
Xu, Hongshuang
Li, Li
Tan, Dengwu
Yan, Hong
The pro- and anti-cancer effects of oxycodone are associated with epithelial growth factor receptor level in cancer cells
title The pro- and anti-cancer effects of oxycodone are associated with epithelial growth factor receptor level in cancer cells
title_full The pro- and anti-cancer effects of oxycodone are associated with epithelial growth factor receptor level in cancer cells
title_fullStr The pro- and anti-cancer effects of oxycodone are associated with epithelial growth factor receptor level in cancer cells
title_full_unstemmed The pro- and anti-cancer effects of oxycodone are associated with epithelial growth factor receptor level in cancer cells
title_short The pro- and anti-cancer effects of oxycodone are associated with epithelial growth factor receptor level in cancer cells
title_sort pro- and anti-cancer effects of oxycodone are associated with epithelial growth factor receptor level in cancer cells
topic Bioenergetics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7007405/
https://www.ncbi.nlm.nih.gov/pubmed/31967294
http://dx.doi.org/10.1042/BSR20193524
work_keys_str_mv AT yuyuqin theproandanticancereffectsofoxycodoneareassociatedwithepithelialgrowthfactorreceptorlevelincancercells
AT lidapeng theproandanticancereffectsofoxycodoneareassociatedwithepithelialgrowthfactorreceptorlevelincancercells
AT duanjian theproandanticancereffectsofoxycodoneareassociatedwithepithelialgrowthfactorreceptorlevelincancercells
AT xuhongshuang theproandanticancereffectsofoxycodoneareassociatedwithepithelialgrowthfactorreceptorlevelincancercells
AT lili theproandanticancereffectsofoxycodoneareassociatedwithepithelialgrowthfactorreceptorlevelincancercells
AT tandengwu theproandanticancereffectsofoxycodoneareassociatedwithepithelialgrowthfactorreceptorlevelincancercells
AT yanhong theproandanticancereffectsofoxycodoneareassociatedwithepithelialgrowthfactorreceptorlevelincancercells
AT yuyuqin proandanticancereffectsofoxycodoneareassociatedwithepithelialgrowthfactorreceptorlevelincancercells
AT lidapeng proandanticancereffectsofoxycodoneareassociatedwithepithelialgrowthfactorreceptorlevelincancercells
AT duanjian proandanticancereffectsofoxycodoneareassociatedwithepithelialgrowthfactorreceptorlevelincancercells
AT xuhongshuang proandanticancereffectsofoxycodoneareassociatedwithepithelialgrowthfactorreceptorlevelincancercells
AT lili proandanticancereffectsofoxycodoneareassociatedwithepithelialgrowthfactorreceptorlevelincancercells
AT tandengwu proandanticancereffectsofoxycodoneareassociatedwithepithelialgrowthfactorreceptorlevelincancercells
AT yanhong proandanticancereffectsofoxycodoneareassociatedwithepithelialgrowthfactorreceptorlevelincancercells